• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

少数接受卵巢切除术的 BRCA1/2 基因突变携带者中出现高度的士气低落,影响生活质量。

High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life.

机构信息

a Department of Obstetrics and Gynaecology , Radboud University Medical Center , Nijmegen , The Netherlands.

b Nijmegen Institute for Scientist-Practitioners in Addiction, Radboud University Nijmegen , Nijmegen , The Netherlands.

出版信息

J Psychosom Obstet Gynaecol. 2018 Jun;39(2):96-104. doi: 10.1080/0167482X.2017.1296429. Epub 2017 Mar 10.

DOI:10.1080/0167482X.2017.1296429
PMID:28279121
Abstract

INTRODUCTION

Demoralization is a relatively neglected issue in which low morale and poor coping result from a stressor such as familial cancer risk. Female BRCA1/2 mutation carriers are highly susceptible for developing breast and ovarian cancer. The aim of this study was to evaluate demoralization in oophorectomized BRCA1/2 mutation carriers and its relation to quality of life.

METHODS

This cross-sectional study examined 288 oophorectomized BRCA1/2 mutation carriers using the following standardized self-report measures: Demoralization Scale, EORTC Quality of Life Questionnaire-C30, State-Trait Anxiety Inventory and the Cancer Worry Scale.

RESULTS

The mean score on the Demoralization Scale was 17.8 (SD 14.0). A clinically significant level of demoralization, defined as a score ≥30, was found in 45 BRCA1/2 mutation carriers (16%). Being highly demoralized was associated with a significantly lower quality of life, and higher levels of physical problems, anxiety and cancer worries. No demographic or clinical factors could predict higher levels of demoralization.

CONCLUSIONS

Our findings established that a clear proportion of oophorectomized BRCA1/2 mutation carriers experience demoralization impacting on their well-being. Further research is needed to explore the natural trajectory of demoralization and the resultant need for support in these women.

摘要

简介

意志消沉是一个相对被忽视的问题,其低士气和应对能力差是由压力源引起的,如家族性癌症风险。女性 BRCA1/2 突变携带者极易患上乳腺癌和卵巢癌。本研究旨在评估行卵巢切除术的 BRCA1/2 突变携带者的意志消沉情况及其与生活质量的关系。

方法

本横断面研究使用以下标准化自我报告措施评估了 288 名行卵巢切除术的 BRCA1/2 突变携带者:意志消沉量表、EORTC 生活质量问卷-C30、状态-特质焦虑量表和癌症担忧量表。

结果

意志消沉量表的平均得分为 17.8(SD 14.0)。45 名 BRCA1/2 突变携带者(16%)的意志消沉程度达到临床显著水平,定义为得分≥30。高度意志消沉与生活质量显著降低、身体问题、焦虑和癌症担忧水平升高有关。没有人口统计学或临床因素可以预测更高水平的意志消沉。

结论

我们的研究结果表明,相当一部分行卵巢切除术的 BRCA1/2 突变携带者经历了意志消沉,影响了她们的幸福感。需要进一步研究来探索意志消沉的自然轨迹以及这些女性对支持的需求。

相似文献

1
High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life.少数接受卵巢切除术的 BRCA1/2 基因突变携带者中出现高度的士气低落,影响生活质量。
J Psychosom Obstet Gynaecol. 2018 Jun;39(2):96-104. doi: 10.1080/0167482X.2017.1296429. Epub 2017 Mar 10.
2
Self-compassion, physical fitness and climacteric symptoms in oophorectomized BRCA1/2 mutation carriers.BRCA1/2 基因突变携带者的自我同情、身体健康与绝经期症状。
Maturitas. 2018 Feb;108:13-17. doi: 10.1016/j.maturitas.2017.11.002. Epub 2017 Nov 3.
3
Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.BRCA1/2 基因突变携带者的监测和预防策略的成本效益分析。
Breast Cancer. 2018 Mar;25(2):141-150. doi: 10.1007/s12282-017-0803-y. Epub 2017 Oct 10.
4
Study on the psychosocial aspects of risk-reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutation carriers in Japan: a preliminary report.日本BRCA1/2突变携带者行降低风险的输卵管卵巢切除术(RRSO)的社会心理方面研究:初步报告
Jpn J Clin Oncol. 2016 Mar;46(3):254-9. doi: 10.1093/jjco/hyv190. Epub 2015 Dec 18.
5
Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.BRCA1 突变携带者行预防性输卵管卵巢切除术的经验及遗传性乳腺癌卵巢癌综合征预防性手术体系在日本的建立:我们未来的挑战。
Jpn J Clin Oncol. 2013 May;43(5):515-9. doi: 10.1093/jjco/hyt036. Epub 2013 Mar 13.
6
The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation.预防性输卵管卵巢切除术对携带 BRCA 突变女性的生活质量和心理困扰的影响。
Psychooncology. 2013 Jan;22(1):212-9. doi: 10.1002/pon.2041. Epub 2011 Sep 13.
7
Relationship of demoralization with anxiety, depression, and quality of life: A Southern European study of Italian and Portuguese cancer patients.道德低落与焦虑、抑郁和生活质量的关系:意大利和葡萄牙癌症患者的南欧研究。
Psychooncology. 2018 Nov;27(11):2616-2622. doi: 10.1002/pon.4824. Epub 2018 Aug 6.
8
Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者乳腺癌术后卵巢切除术对生存的影响。
JAMA Oncol. 2015 Jun;1(3):306-13. doi: 10.1001/jamaoncol.2015.0658.
9
Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.BRCA1和BRCA2种系突变携带者预防性标本中的偶发性癌,重点关注输卵管病变:6例报告及文献复习
Am J Surg Pathol. 2006 Oct;30(10):1222-30. doi: 10.1097/01.pas.0000202161.80739.ac.
10
Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.对BRCA1和BRCA2突变携带者进行降低风险的输卵管卵巢切除术所获得的卵巢和输卵管上皮中γ-H2AX和p53核表达水平的定量分析。
Int J Gynecol Pathol. 2014 May;33(3):309-16. doi: 10.1097/PGP.0b013e31829c673b.

引用本文的文献

1
Exploring the relationship between illness perception, self-transcendence, and demoralization in patients with lung cancer: A latent profile and mediation analysis.探索肺癌患者的疾病认知、自我超越与士气低落之间的关系:一项潜在剖面与中介分析。
Asia Pac J Oncol Nurs. 2024 Dec 10;12:100638. doi: 10.1016/j.apjon.2024.100638. eCollection 2025 Dec.
2
Theory-based training to promote breast cancer screening among women with breast cancer worries: randomized controlled trial.基于理论的培训以促进有乳腺癌担忧的女性进行乳腺癌筛查:随机对照试验。
Sao Paulo Med J. 2020 Mar;138(2):158-166. doi: 10.1590/1516-3180.2019.033430092019. Epub 2020 Jun 1.